TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

VIVUS, Inc. Under Long Term Investor Investigation

  • If you are a current long term investor in common stock of VIVUS, Inc. (NASDAQ:VVUS), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

An investor in VIVUS filed a lawsuit on behalf of those who purchased common stock of VIVUS, Inc. (VVUS) between September 9, 2009 and July 15, 2010 against VIVUS, Inc. over alleged violations of Federal Securities Laws in connection with its New Drug Application with the Food and Drug Administration for VIVUS product Qnexa as an obesity drug. Meanwhile an investigation on behalf of c...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: